March 24, 2021 Experience Baidu HK$23.9 billion IPO and secondary listing on the Hong Kong Stock Exchange In addition to the HKEX listing, Baidu’s ADSs trade on the Nasdaq Global Select Market
March 24, 2021 Experience Shuifa Group $200 million bonds offering We advised the joint lead managers on the Regulation S bonds offering
March 22, 2021 Experience China South City Holdings $50 million high-yield notes reopening We advised the initial purchaser on the Regulation S offering
March 11, 2021 Experience Fujian Yango $50 million high-yield notes offering We advised the joint lead managers on the Regulation S offering
March 9, 2021 Experience China South City Holdings $175 million high-yield notes offering We advised the initial purchasers on the offering
March 1, 2021 Experience I-Mab $177 million follow-on secondary offering of ADSs We advised the underwriters on the equity offering
February 26, 2021 Experience JOINN Laboratories HK$6.5 billion IPO We advised JOINN Laboratories on its IPO and HKEX listing.
February 19, 2021 Experience Fantasia $150 million high-yield notes reopening and concurrent tender offer We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
February 19, 2021 Experience InnoCare Pharma HK$3.04 billion share placement We advised InnoCare Pharma in the placement of new shares